Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study

Vaccines

Máxima Mendez Castillo¹  Ezequiel Forte²  ManuelAlfonso Baños González³  JohnJairo Araujo⁴  LeonardoJosué Ramírez Zambrano⁵  Luz Cabral⁶  Bernardo Spitz⁷  Jorge Camilletti⁸  Ricardo Lopez Santi⁸  Juan Erriest⁸  Carmen Roa⁹  Piero Custodio–Sanchez^1,10  Roberto Flores^1,11  Mirecly Guzman Ramos^1,12  Gustavo Solache Ortiz^1,13  Adrián Baranchuk^1,14  Álvaro Sosa Liprandi^1,15  EzequielJosé Zaidel^1,15  JuanMartín Busso^1,16 

[1] CEDIMAT, Santo Domingo 10514, Dominican Republic;CENDIC Centro Diagnóstico Cardiovascular, Concordia E3202, Argentina;Cardiology Department, Universidad Juarez Autónoma de Tabasco, Villahermosa Tabasco 86040, Mexico;Centro Cardiovascular Somer Incare, Rionegro 054040, Colombia;Centro Clínico San Cristobal, San Cristobal 5001, Venezuela;Centro Médico Nacional-Hospital Nacional Itauguá, Itauguá 2740, Paraguay;Clínica Cuyo, Mendoza M5500, Argentina;Hospital Italiano de La Plata, La Plata B1900, Argentina;Hospital Metropolitano de Santiago, Santo Domingo 51000, Dominican Republic;Hospital Nacional Almanzor Aguinaga Asenjo -Essalud, Chiclayo 14001, Peru;Hospital Ramón Carrillo, Santiago del Estero G4200, Argentina;IVSS Dr Luis Guada Lacau, Valencia 2300, Venezuela;Instituto de Cardiología Preventiva, San Juan del Río 76800, Mexico;Queen’s University, Kingston, ON K7L 3N6, Canada;Sanatorio Güemes, Buenos Aires C1180AAX, Argentina;Sanatorio San José, Buenos Aires c1425, Argentina;

关键词: COVID-19;    SARS-CoV-2;    Influenza vaccination;    pneumococcal vaccination;    cardio–metabolic;   

DOI  :  10.3390/vaccines9020123

来源: DOAJ

【 摘 要 】

Background: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. Methods: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. Results: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, p < 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42, p < 0.001), age (IV = OR 1.023, PV = OR 1.035, p < 0.001), and incomes (IV = OR 1.28, PV = OR 1.58, p < 0.001) were predictors for vaccination. Conclusions: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.

【 授权许可】

Unknown